Correction to: Scientific Reports https://doi.org/10.1038/s41598-020-69300-8, published online 24 July 2020
In the original version of this Article, the author Josefin Bartholdson Scott was incorrectly indexed. This error has now been corrected.
. 2021 Mar 26;11:7366. doi: 10.1038/s41598-021-86902-y
Publisher Correction: A novel therapeutic antibody screening method using bacterial high-content imaging reveals functional antibody binding phenotypes of Escherichia coli ST131
Mailis Maes
1, Zoe A Dyson
1,2,3, Sarah E Smith
4, David A Goulding
5, Catherine Ludden
3, Stephen Baker
1, Paul Kellam
4,6, Stephen T Reece
4, Gordon Dougan
1, Josefin Bartholdson Scott
1,✉
Mailis Maes
1Department of Medicine, Cambridge Institute for Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK
Find articles by Mailis Maes
Zoe A Dyson
1Department of Medicine, Cambridge Institute for Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK
2Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC 3004 Australia
3London School of Hygiene and Tropical Medicine, London, UK
Find articles by Zoe A Dyson
Catherine Ludden
3London School of Hygiene and Tropical Medicine, London, UK
Find articles by Catherine Ludden
Stephen Baker
1Department of Medicine, Cambridge Institute for Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK
Find articles by Stephen Baker
Paul Kellam
4Kymab Ltd, Babraham Research Campus, Cambridge, UK
6Department of Infectious Disease, Imperial College London, London, UK
Find articles by Paul Kellam
Stephen T Reece
4Kymab Ltd, Babraham Research Campus, Cambridge, UK
Find articles by Stephen T Reece
Gordon Dougan
1Department of Medicine, Cambridge Institute for Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK
Find articles by Gordon Dougan
Josefin Bartholdson Scott
1Department of Medicine, Cambridge Institute for Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK
Find articles by Josefin Bartholdson Scott
1Department of Medicine, Cambridge Institute for Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, UK
2Department of Infectious Diseases, Central Clinical School, Monash University, Melbourne, VIC 3004 Australia
3London School of Hygiene and Tropical Medicine, London, UK
4Kymab Ltd, Babraham Research Campus, Cambridge, UK
5Wellcome Sanger Institute, Hinxton, UK
6Department of Infectious Disease, Imperial College London, London, UK
✉
Corresponding author.
Collection date 2021.
© The Author(s) 2021
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC7997916 PMID: 33772104
This corrects the article "A novel therapeutic antibody screening method using bacterial high-content imaging reveals functional antibody binding phenotypes of Escherichia coli ST131" in volume 10, 12414.